Background <p>Robotic-assisted surgery is established in several specialties, but its vascular surgery application remains limited. We assessed Irish infrastructural readiness and governance to inform a national feasibility programme.</p> Methods <p>A structured environmental scan of Irish tertiary centres was performed. Public sources (hospital/health-service websites, reports, press releases, procurement notices, training pages, professional societies, and newspaper articles) were reviewed to October 2025. We recorded robotic platform availability, co-location with vascular services, robotics governance structures, and vascular representation.</p> Results <p>Nine HSE Model-4 hospitals were identified, and their corresponding robotic programmes were assessed. All hospitals report access to surgical robotic platforms and institutional supports. All are co-located with vascular surgery units. No vascular robotic programmes exists in Ireland and vascular representation in national governance is simultaneously absent.</p> Conclusions <p>Ireland appears ready for a centralised, mentored pilot with prospective clinical and economic evaluation. International evidence suggests feasibility with possible perioperative advantages and requires further investigation.</p> Clinical trial registration <p>Not applicable.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Aortic robotic surgery in Ireland: infrastructure without implementation – Is now the time to act?

  • Morgan T. McLoughlin,
  • Gergely Gosi

摘要

Background

Robotic-assisted surgery is established in several specialties, but its vascular surgery application remains limited. We assessed Irish infrastructural readiness and governance to inform a national feasibility programme.

Methods

A structured environmental scan of Irish tertiary centres was performed. Public sources (hospital/health-service websites, reports, press releases, procurement notices, training pages, professional societies, and newspaper articles) were reviewed to October 2025. We recorded robotic platform availability, co-location with vascular services, robotics governance structures, and vascular representation.

Results

Nine HSE Model-4 hospitals were identified, and their corresponding robotic programmes were assessed. All hospitals report access to surgical robotic platforms and institutional supports. All are co-located with vascular surgery units. No vascular robotic programmes exists in Ireland and vascular representation in national governance is simultaneously absent.

Conclusions

Ireland appears ready for a centralised, mentored pilot with prospective clinical and economic evaluation. International evidence suggests feasibility with possible perioperative advantages and requires further investigation.

Clinical trial registration

Not applicable.